ロード中...
Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research
Adjuvant chemotherapy for non-small-cell lung carcinoma (NSCLC) is a debated issue in clinical oncology. Although it is considered a standard for resected stage II-IIIA patients according to the available guidelines, many questions are still open. Among them, it should be acknowledged that the treat...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3284429/ https://ncbi.nlm.nih.gov/pubmed/22206620 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-30-115 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|